Press Releases

Date	Title	Company
25-Apr-2023	Introducing the Copley Impactor Genie™ IG 200i, a two-in-one solution for quicker, more efficient inhaled product testing	Copley Scientific
25-Apr-2023	InnoScot Health and Openhouse ready for launch of emergency Surgical bag at Retrieval Conference	InnoScot Health
25-Apr-2023	Orgenesis CEO Vered Caplan featured in keynote series at INTERPHEX conference to discuss innovations in cell & gene therapy manufacturing	Orgenesis
25-Apr-2023	Minoryx presents positive interim results from NEXUS registration study for leriglitazone targeting pediatric ALD patients with cerebral adrenoleukodystrophy (cALD)	Minoryx Therapeutics
25-Apr-2023	Vedanta Biosciences Announces $106.5 Million Financing to Advance Pipeline of Defined Bacterial Consortia Therapies	Vedanta Biosciences
25-Apr-2023	Parkinson's device company secures strategic investment from Crimson International Investment	PD Neurotechnology
25-Apr-2023	Launching the IBMS takeover of Harvey’s Gang	IBMS
25-Apr-2023	Pharmaceutical Blockchain Market to Notice Utmost Growth of US$ 25.6 Billion, Growing with Tremendous CAGR of 55% in the Forecast Period 2023-2030	The Wire Times
25-Apr-2023	Nucleic Acid Based Drugs Market to Perceive 19.80% of Highest CAGR by Forecast 2029, Size, Share, Trends, Demands and Growth Factors	The Wire Times
25-Apr-2023	Alchemab Therapeutics to present data profiling a novel antibody to Huntingtin Exon 1 at the CHDI Annual Huntington’s Disease Therapeutics Conference	Alchemab Therapeutics
25-Apr-2023	Financial Results for the Year Ended 31 December 2022, Publication of Annual Report and Notice of Annual General Meeting	Arix Bioscience plc
25-Apr-2023	OKYO Pharma Announces Activation of First Clinical Trial Site in the U.S. for the Phase 2 Trial Evaluating OK-101 for the Treatment of Dry Eye Disease	OKYO Pharma
25-Apr-2023	Vamorolone NDA mid-cycle review meeting by FDA completed	Santhera Pharmaceuticals
25-Apr-2023	NEW EUROPEAN ANALYSIS REINFORCES 19 DAY COMMERCIAL MANUFACTURING TURNAROUND TIME FOR YESCARTA® (AXICABTAGENE CILOLEUCEL) FOR ADULT PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA	Kite, a Gilead Company
25-Apr-2023	CARMAT obtains non-dilutive financing of €13.2 million within the framework of the “France 2030” plan	CARMAT
25-Apr-2023	Protective Mask Market is expected to grow at a negative CAGR of -34.5% by 2032 \| FMI Analyst	MARKITWIRED
25-Apr-2023	eClinical Solutions and Software Market are expected to rise at a CAGR of 12.1% and be worth around US$ 29.1 billion by 2033 \| FMI Study	MARKITWIRED
25-Apr-2023	Blood Plasma Market at a CAGR of 10.60% with Business Growth Tactics, Future Strategies, Industrial Demand and More	The Wire Times
25-Apr-2023	Human Growth Hormone Treatment and Drugs Market is expected to reach US$ 5.26 Billion by 2033, with sales revenue 3.7% CAGR	MARKITWIRED
25-Apr-2023	Hernia Repair Devices Market is projected to reach a valuation of US$ 12.3 billion by 2033, at a CAGR of 9.4% \| FMI	MARKITWIRED